Osaic Holdings
CSTL icon

Osaic Holdings’s Castle Biosciences CSTL Stock Holding History

Osaic Holdings’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.4K Buy
1,191
+334
+39% +$7.44K ﹤0.01% 5892
2026
Q1 		$21K Sell
857
-35,547
-98% -$1.16M ﹤0.01% 5823
2025
Q4 		$1.42M Buy
36,404
+35,996
+8,823% +$1.16M ﹤0.01% 2379
2025
Q3 		$9.26K Buy
408
+209
+105% +$4.25K ﹤0.01% 6412
2025
Q2 		$4.01K Sell
199
-3
-1% -$56 ﹤0.01% 6661
2025
Q1 		$4.04K Buy
202
+188
+1,343% +$4.66K ﹤0.01% 6282
2024
Q4 		$373 Sell
14
-5,134
-100% -$156K ﹤0.01% 7077
2024
Q3 		$147K Buy
5,148
+648
+14% +$16.5K ﹤0.01% 3909
2024
Q2 		$98K Sell
4,500
-956
-18% -$21.3K ﹤0.01% 4162
2024
Q1 		$121K Sell
5,456
-2,883
-35% -$62.7K ﹤0.01% 4106
2023
Q4 		$180K Buy
8,339
+1,779
+27% +$31.3K ﹤0.01% 4012
2023
Q3 		$111K Buy
6,560
+2,934
+81% +$51.3K ﹤0.01% 4430
2023
Q2 		$49.7K Buy
3,626
+984
+37% +$19.9K ﹤0.01% 4940
2023
Q1 		$60K Buy
2,642
+178
+7% +$4.35K ﹤0.01% 4828
2022
Q4 		$59K Sell
2,464
-60
-2% -$1.39K ﹤0.01% 4805
2022
Q3 		$65K Buy
2,524
+156
+7% +$4.37K ﹤0.01% 4699
2022
Q2 		$52K Sell
2,368
-3,879
-62% -$90.1K ﹤0.01% 4924
2022
Q1 		$279K Sell
6,247
-998
-14% -$41.2K ﹤0.01% 3741
2021
Q4 		$310K Buy
7,245
+678
+10% +$35.4K ﹤0.01% 3527
2021
Q3 		$437K Buy
6,567
+495
+8% +$34.8K ﹤0.01% 3173
2021
Q2 		$444K Buy
6,072
+3,006
+98% +$199K ﹤0.01% 3147
2021
Q1 		$210K Buy
3,066
+774
+34% +$58.2K ﹤0.01% 3691
2020
Q4 		$154K Buy
2,292
+2,248
+5,109% +$122K ﹤0.01% 3712
2020
Q3 		$2K Buy
44
+42
+2,100% +$1.87K ﹤0.01% 5832
2020
Q2 		$0 Hold
2
– – ﹤0.01% 6143
2020
Q1 		$0 Buy
+2
New +$60 ﹤0.01% 6082

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's CSTL Position: Q2 2026 in Review

Osaic Holdings increased its Castle Biosciences (CSTL) stake by 39% in Q2 2026, buying an estimated $7.44K and bringing the position to 1,191 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5892.

Osaic Holdings first reported a position in CSTL in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.42M in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Osaic Holdings held 1,191 shares of Castle Biosciences worth $28.4K as of Q2 2026.
  • Osaic Holdings bought 334 Castle Biosciences shares in Q2 2026, an estimated $7.44K.
  • Castle Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5892 holding.
  • Osaic Holdings first reported a position in Castle Biosciences in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Castle Biosciences position peaked at $1.42M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.